TriSalus Life Sciences, Inc.: capital expenditure payments
Capital expenditure payments for TriSalus Life Sciences, Inc. Inspect selected reporting periods, original units and SEC filing links; download the financial history.
All TriSalus Life Sciences, Inc. financial histories
What this measure means
Cash payments to acquire property, plant and equipment. This taxonomy concept does not capture every form of investment or acquisition.
Exact concept: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. Each value covers an annual-duration reporting interval, shown with both start and end dates. Different units remain separate; no currency conversion or interpolation is applied.
Coverage of this history
Selected reporting periods run from 2022-01-01 to 2025-12-31. The SEC response was captured on 2026-09-21.
Selected filing history
| Period start | Period end | Value | Unit | Filed | Source filing |
|---|---|---|---|---|---|
| 2025-01-01 | 2025-12-31 | 918,000 | USD | 2026-03-05 | 10-K · 0001628280-26-015163 |
| 2024-01-01 | 2024-12-31 | 345,000 | USD | 2026-03-05 | 10-K · 0001628280-26-015163 |
| 2023-01-01 | 2023-12-31 | 588,000 | USD | 2025-05-30 | 10-K/A · 0001826667-25-000070 |
| 2022-01-01 | 2022-12-31 | 655,000 | USD | 2024-04-11 | 10-K · 0001826667-24-000005 |
Related financial histories
- TriSalus Life Sciences, Inc.: total assets
- TriSalus Life Sciences, Inc.: total liabilities
- TriSalus Life Sciences, Inc.: stockholders equity
- TriSalus Life Sciences, Inc.: cash and cash equivalents
- TriSalus Life Sciences, Inc.: net income or loss
- TriSalus Life Sciences, Inc.: operating cash flow
- TriSalus Life Sciences, Inc.: contract revenue excluding tax
- TriSalus Life Sciences, Inc.: financing cash flow
- TriSalus Life Sciences, Inc.: investing cash flow
- TriSalus Life Sciences, Inc.: retained earnings or deficit
- TriSalus Life Sciences, Inc.: basic weighted-average shares
- TriSalus Life Sciences, Inc.: diluted weighted-average shares
- TriSalus Life Sciences, Inc.: basic earnings per share
- TriSalus Life Sciences, Inc.: diluted earnings per share
- TriSalus Life Sciences, Inc.: income tax expense or benefit
- TriSalus Life Sciences, Inc.: share-based compensation expense
- TriSalus Life Sciences, Inc.: operating income or loss
- TriSalus Life Sciences, Inc.: current assets
- TriSalus Life Sciences, Inc.: current liabilities
- TriSalus Life Sciences, Inc.: net current accounts receivable
- TriSalus Life Sciences, Inc.: net inventory
- TriSalus Life Sciences, Inc.: gross profit
- TriSalus Life Sciences, Inc.: research and development expense
Inspect the source
- Entity
- TriSalus Life Sciences, Inc. / CIK 0001826667
- Captured
- 2026-09-21T17:29:43.307Z
- SEC response SHA-256
a4c13dbc017a0784639677dccc5fbfe360cc95e9a466af6f77d5982f4dd1e272
Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON
Latest-filed annual-report facts per unit and reporting period at capture time. Duration facts cover 300 to 400 days. This selection can include restatements and is not a point-in-time backtest dataset. Missing concepts are omitted, never zero-filled. Values retain original units and are not currency converted. Extended concepts require compatible unit shapes and at least three reporting ends with changing values within one unit. Constant or incompatible added histories are omitted.
Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.
Use this in research
A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.
These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.
Research methodology · Execution and cost assumptions · Check backtest overfitting
Build with the open-source tools
Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.
- Get an API key and run your first validation
- Connect the MCP server to your coding assistant
- Inspect the ALPHAC engine on GitHub
- Read the MCP server source and integration examples
Read the published dataset with Python
import json
from urllib.request import urlopen
with urlopen("https://canlicapital.com/company-data/0001826667.json") as response:
record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
print(concept["tag"], next(iter(concept["observations"])))